From: A population-based cohort study of mortality of intensive care unit patients with liver cirrhosis
 | n | 30-day mortality | |||
---|---|---|---|---|---|
Deaths | Mortality, % | OR | (95% CI)a | ||
Pre-ICU characteristics within 2 years | |||||
 No LC | 37,197 | 4046 | 10.9 | 1.00 | (reference) |
 LC without liver cancer | 25,758 | 3705 | 14.4 | 1.48 | (1.41 to 1.56) |
 LC with liver cancer | 11,439 | 2190 | 19.2 | 1.85 | (1.74 to 1.97) |
 LC with no HBV and HCV | 22,258 | 3366 | 15.1 | 1.55 | (1.47 to 1.63) |
 LC with HBV or HCV | 13,573 | 2288 | 16.9 | 1.67 | (1.58 to 1.77) |
 LC with HBV and HCV | 1366 | 241 | 17.6 | 1.75 | (1.50 to 2.03) |
 LC without ADS | 34,496 | 5450 | 15.8 | 1.59 | (1.52 to 1.66) |
 LC with ADS | 2701 | 445 | 16.5 | 1.82 | (1.62 to 2.04) |
 LC without jaundice | 33,978 | 5171 | 15.2 | 1.54 | (1.47 to 1.62) |
 LC with jaundice | 3219 | 724 | 22.5 | 2.23 | (2.03 to 2.45) |
 LC without ascites | 26,352 | 3332 | 12.6 | 1.30 | (1.23 to 1.37) |
 LC with ascites | 10,845 | 2563 | 23.6 | 2.32 | (2.19 to 2.46) |
 LC without GI hemorrhage | 27,652 | 4114 | 14.9 | 1.50 | (1.43 to 1.58) |
 LC with GI hemorrhage | 9545 | 1781 | 18.7 | 1.90 | (1.78 to 2.03) |
 LC without hepatic coma | 29,252 | 4102 | 14.0 | 1.43 | (1.37 to 1.37) |
 LC with hepatic coma | 7945 | 1793 | 22.6 | 2.21 | (2.07 to 2.36) |
 LC with 0 admission | 25,677 | 3378 | 13.2 | 1.33 | (1.26 to 1.40) |
 LC with 1 admission | 6600 | 1411 | 21.4 | 2.16 | (2.01 to 2.32) |
 LC with 2 admissions | 2449 | 521 | 21.3 | 2.14 | (1.92 to 2.38) |
 LC with 3 admissions | 1059 | 248 | 23.4 | 2.37 | (2.03 to 2.76) |
 LC with ≥4 admissions | 1412 | 337 | 23.9 | 2.52 | (2.20 to 2.89) |
 LC with 0 days of hospital stay | 25,677 | 3378 | 13.2 | 1.33 | (1.26 to 1.40) |
 LC with 1–9 days of hospital stay | 5144 | 996 | 19.4 | 1.92 | (1.77 to 2.08) |
 LC with 10–19 days of hospital stay | 3022 | 664 | 22.0 | 2.23 | (2.02 to 2.45) |
 LC with 20–29 days of hospital stay | 1312 | 305 | 23.3 | 2.30 | (2.00 to 2.65) |
 LC with ≥30 days of hospital stay | 2042 | 552 | 27.0 | 2.97 | (2.66 to 3.31) |
 LC without albumin supplement | 23,279 | 3140 | 13.5 | 1.40 | (1.33 to 1.47) |
 LC with albumin supplement | 13,918 | 2755 | 19.8 | 1.93 | (1.83 to 2.04) |
 LC without alcohol-related illness | 24,894 | 3581 | 14.4 | 1.25 | (1.20 to 1.31) |
 LC with alcohol-related illness | 12,303 | 2314 | 18.8 | 1.75 | (1.66 to 1.85) |
 LC without hospitalizations | 7214 | 756 | 10.5 | 0.91 | (0.84 to 0.98) |
 LC with hospitalizations | 29,983 | 5139 | 17.1 | 1.52 | (1.46 to 1.58) |
Reasons for ICU admission | |||||
 Digestive disease, no LC | 10,198 | 550 | 5.4 | 1.00 | (reference) |
 Digestive disease, LC | 10,198 | 1511 | 14.8 | 3.23 | (2.91 to 3.58) |
 Cancer, no LC | 6726 | 1031 | 15.3 | 1.00 | (reference) |
 Cancer, LC | 6726 | 1154 | 17.2 | 1.15 | (1.05 to 1.27) |
 Respiratory disease, no LC | 4524 | 837 | 18.5 | 1.00 | (reference) |
 Respiratory disease, LC | 4524 | 986 | 21.8 | 1.24 | (1.12 to 1.38) |
 Circulatory disease, no LC | 4385 | 384 | 8.8 | 1.00 | (reference) |
 Circulatory disease, LC | 4385 | 530 | 12.1 | 1.47 | (1.28 to 1.70) |
 Infectious disease, no LC | 3518 | 807 | 22.9 | 1.00 | (reference) |
 Infectious disease, LC | 3518 | 983 | 27.9 | 1.32 | (1.19 to 1.48) |
 Injury and poisoning, no LC | 2918 | 192 | 6.6 | 1.00 | (reference) |
 Injury and poisoning, LC | 2918 | 345 | 11.8 | 1.95 | (1.61 to 2.35) |
 Symptom-defined conditions, no LC | 862 | 123 | 14.3 | 1.00 | (reference) |
 Symptom-defined conditions, LC | 862 | 194 | 22.5 | 1.86 | (1.43 to 2.42) |
 Genitourinary disease, no LC | 762 | 38 | 5.0 | 1.00 | (reference) |
 Genitourinary disease, LC | 762 | 59 | 7.7 | 1.74 | (1.10 to 2.75) |
 Endocrine disease, no LC | 605 | 24 | 4.0 | 1.00 | (reference) |
 Endocrine disease, LC | 605 | 31 | 5.1 | 1.36 | (0.76 to 2.43) |
 Musculoskeletal disease, no LC | 598 | 17 | 2.8 | 1.00 | (reference) |
 Musculoskeletal disease, LC | 598 | 42 | 7.0 | 3.49 | (1.79 to 6.82) |
 Mental disorder, no LC | 278 | 0 | 0.0 | 1.00 | (reference) |
 Mental disorder, LC | 278 | 0 | 0.0 | – | – |
 Neurological disease, no LC | 304 | 11 | 3.6 | 1.00 | (reference) |
 Neurological disease, LC | 304 | 25 | 8.2 | 2.94 | (1.30 to 6.65) |
 Skin disease, no LC | 291 | 7 | 2.4 | 1.00 | (reference) |
 Skin disease, LC | 291 | 8 | 2.8 | 1.23 | (0.35 to 4.39) |
 Tumor, no LC | 254 | 2 | 0.8 | 1.00 | (reference) |
 Tumor, LC | 254 | 5 | 2.0 | 3.33 | (0.51 to 21.8) |
 Blood disease, no LC | 76 | 5 | 6.6 | 1.00 | (reference) |
 Blood disease, LC | 76 | 3 | 4.0 | 0.38 | (0.05 to 2.84) |
 Congenital anomalies, no LC | 40 | 1 | 2.5 | 1.00 | (reference) |
 Congenital anomalies, LC | 40 | 0 | 0.0 | – | – |
 Disease of perinatal period, no LC | 33 | 1 | 3.0 | 1.00 | (reference) |
 Disease of perinatal period, LC | 33 | 0 | 0.0 | – | – |
 Complications of pregnancy, no LC | 7 | 0 | 0.0 | 1.00 | (reference) |
 Complications of pregnancy, LC | 7 | 1 | 14.3 | – | – |
 0 CCI score, no LC | 10,476 | 1066 | 10.2 | 1.00 | (reference) |
 0 CCI score, LC | 1165 | 101 | 8.7 | 0.97 | (0.77 to 1.23) |
 1 CCI score, no LC | 8899 | 731 | 8.2 | 1.00 | (reference) |
 1 CCI score, LC | 6656 | 818 | 12.3 | 1.38 | (1.21 to 1.58) |
 2 CCI score, no LC | 6573 | 592 | 9.0 | 1.00 | (reference) |
 2 CCI score, LC | 5116 | 592 | 11.6 | 1.49 | (1.31 to 1.70) |
 3 CCI score, no LC | 3897 | 355 | 9.1 | 1.00 | (reference) |
 3 CCI score, LC | 5478 | 760 | 13.9 | 1.45 | (1.25 to 1.69) |
 4 CCI score, no LC | 1823 | 209 | 11.5 | 1.00 | (reference) |
 4 CCI score, LC | 7085 | 1325 | 18.7 | 1.40 | (1.17 to 1.67) |
  ≥ 5 CCI score, no LC | 5529 | 1093 | 19.8 | 1.00 | (reference) |
  ≥ 5 CCI score, LC | 11,697 | 2299 | 19.7 | 1.08 | (0.99 to 1.18) |